Treatment of Delayed Puberty in Females
Diagnosis and Assessment
- Delayed puberty in females is defined as absence of breast development by age 13 years, failure to progress in pubertal stage for ≥12 months, or primary amenorrhea by age 16 years 3, 4
- Laboratory evaluation should include baseline hormone levels at age 13 years, and additional testing for abnormal hormone levels in patients with delayed puberty signs 1, 5
Treatment Approach
- Hormone replacement therapy with estrogen, followed by progesterone, is the standard treatment for delayed puberty in females to normalize ovarian hormone levels and promote pubertal development 1, 2
- Estrogen replacement therapy should be initiated to trigger initial pubertal signs, promote proper pubertal height spurt, achieve adequate feminization, and improve bone mass accrual 6
- Treatment should begin between ages 11-13 years to facilitate positive psychosocial adaptation, and a serum hormone level cut-off is a reasonable indicator for pubertal induction 6
- Estrogen may be administered via oral, micronized, or transdermal preparations, and the timing and tempo of estrogen HRT must be carefully managed to ensure acceptable final height 1, 2
- Progesterone therapy should be added after estrogen has been administered for 1-2 years or when breakthrough bleeding occurs, to avoid unopposed estrogen effect and maintain endometrial health in women with a uterus 1, 2
Medication Considerations
- Estrogen formulations are available as oral tablets, transdermal patches, or gels, and transdermal routes may be preferred for patients with liver disease or metabolic risk factors 1, 2, 6
- Monitoring during treatment should include periodic assessment of the hypothalamic-pituitary-gonadal axis without HRT, and bone mineral density evaluation in hypogonadal patients 1, 2
Special Considerations
- Proper treatment improves cardiovascular and bone health 2
- Referrals to endocrinology/gynecology or reproductive endocrinology may be necessary for delayed puberty, persistently abnormal hormone levels, or hypogonadism, or for fertility concerns 1, 2
- Treatment must be individualized based on factors such as age, bone age, growth velocity, and final height expectation 6
- Many patients erroneously assume that menstrual cycles indicate fertility; proper counseling about fertility status is essential 2